Connolly Hospital

The Rheumatology Department at Connolly Hospital focuses on immune system disorders. Conditions include systemic lupus erythematosus. Research also examines Addison’s disease. A further target is active idiopathic inflammatory myopathy.

• Systemic Lupus Erythematosus
• Addison’s Disease
• Active Idiopathic Inflammatory Myopathy
• Systemic Sclerosis

Trials evaluate new agents for reducing disease activity, enhancing quality of life, and stabilising immune function.

Studies address musculoskeletal disease. One focus is active idiopathic inflammatory myopathy. Another interest is the impact of disease on systemic sclerosis.

• Active Idiopathic Inflammatory Myopathy
• Systemic Sclerosis

The aim is to test innovative treatments that preserve muscle strength and reduce chronic pain while monitoring long‑term safety.

The site investigates respiratory tract diseases. Key conditions include idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

• Idiopathic Pulmonary Fibrosis
• Progressive Pulmonary Fibrosis

Studies aim to slow the decline in forced vital capacity and improve overall lung health.

Research targets digestive system disease. The primary focus is ulcerative colitis.

• Moderately to severely active ulcerative colitis

Trials compare emerging oral agents with standard care to achieve endoscopic improvement and lasting symptomatic remission.

The department also studies nutritional and metabolic disorders. A central condition is obesity.

• Obesity

Objectives include evaluating weight reduction, metabolic marker changes, and overall cardiovascular safety.

Investigations include skin and connective tissue disease. A major focus is systemic sclerosis.

• Systemic Sclerosis

Clinical work aims to protect lung function, improve skin scores, and reduce the overall disease burden.